Skip to main content

Table 4 Lab values

From: A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss

Variable LLLT (N = 15) Lorcaserin (N = 14) Combination (N = 13a)
RBC
 Baseline 4.59 ± 0.32 4.75 ± 0.43 4.80 ± 0.41
 Week 12 4.61 ± 0.29 4.70 ± 0.42 4.65 ± 0.34
 Delta +0.01 ± 0.20 −0.06 ± 0.17 −0.15 ± 0.26
Hemoglobin
 Baseline 13.77 ± 0.92 14.34 ± 1.26 14.00 ± 1.26
 Week 12 13.83 ± 0.81 14.08 ± 1.28 13.55 ± 1.15
 Delta +0.07 ± 0.57 −0.26 ± 0.61 −0.45 ± 0.86
Hematocrit
 Baseline 41.35 ± 2.07 42.81 ± 3.00 42.17 ± 2.82
 Week 12 41.53 ± 2.13 42.03 ± 2.92 40.78 ± 2.67
 Delta +0.17 ± 1.82 −0.77 ± 1.93 −1.39 ± 2.37
MCV
 Baseline 90.19 ± 4.38 90.21 ± 3.18 88.09 ± 4.07
 Week 12 90.29 ± 3.69 89.66 ± 3.76 87.86 ± 4.00
 Delta +0.10 ± 2.05 −0.56 ± 2.08 −0.23 ± 1.86
RDW
 Baseline 13.23 ± 0.74 13.11 ± 0.50 13.41 ± 0.61
 Week 12 13.19 ± 0.58 12.96 ± 0.49 13.22 ± 0.69
 Delta −0.04 ± 0.40 −0.14 ± 0.37 −0.19 ± 0.48
WBC
 Baseline 6.83 ± 1.71 7.20 ± 1.45 6.98 ± 1.28
 Week 12 5.99 ± 1.41 6.81 ± 2.11 6.32 ± 1.57
 Delta −0.83 ± 1.26* −0.39 ± 1.08 −0.66 ± 1.11
Neutrophils
 Baseline 4.03 ± 1.58 4.15 ± 1.12 4.29 ± 1.08
 Week 12 3.30 ± 1.10 3.99 ± 1.72 3.78 ± 1.20
 Delta −0.74 ± 1.17* −0.16 ± 0.99 −0.51 ± 0.77*
Lymphocytes
 Baseline 2.04 ± 0.41 2.22 ± 0.55 2.00 ± 0.39
 Week 12 1.93 ± 0.38 2.03 ± 0.41 1.84 ± 0.53
 Delta −0.11 ± 0.25 −0.19 ± 0.43 −0.16 ± 0.39
Monocytes
 Baseline 0.51 ± 0.13 0.60 ± 0.19 0.49 ± 0.13
 Week 12 0.47 ± 0.13 0.58 ± 0.22 0.47 ± 0.10
 Delta −0.05 ± 0.12 −0.02 ± 0.12 −0.03 ± 0.06
Eosinophils
 Baseline 0.22 ± 0.12 0.18 ± 0.11 0.16 ± 0.05
 Week 12 0.26 ± 0.18 0.17 ± 0.11 0.19 ± 0.15
 Delta +0.04 ± 0.11 −0.01 ± 0.06 +0.03 ± 0.15
Basophils
 Baseline 0.03 ± 0.02 0.04 ± 0.03 0.03 ± 0.02
 Week 12 0.04 ± 0.02 0.04 ± 0.03 0.03 ± 0.01
 Delta +0.01 ± 0.02 −0.00 ± 0.02 +0.00 ± 0.01
Platelets
 Baseline 251.4 ± 56.6 287.0 ± 69.3 292.9 ± 60.3
 Week 12 253.4 ± 51.2 277.1 ± 70.9 287.4 ± 47.7
 Delta +2.0 ± 20.8 −9.9 ± 27.3 −5.5 ± 26.0
  1. *p < 0.05, for paired t-test comparing week 12 versus baseline
  2. aOf the 15 subjects assigned to the combination group, 2 discontinued prior to week 12 and are not included in the analysis